Moderna Stock Investor Sentiment

MRNA Stock  USD 117.31  5.38  4.39%   
About 65% of Moderna's investor base is looking to short. The analysis of the overall investor sentiment regarding Moderna suggests that many traders are alarmed. Moderna's investor sentiment overview provides quick insight into current market opportunities from investing in Moderna. The current market sentiment, together with Moderna's historical and current headlines, can help investors time the market. In addition, many technical investors use Moderna stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

35

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Moderna's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Moderna.
Moderna stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Moderna daily returns and investor perception about the current price of Moderna as well as its diversification or hedging effects on your existing portfolios.

Moderna Historical Sentiment

Although Moderna's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Moderna, such as negative comments on social media and news outlets, may cause fear in the market and push Moderna's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Moderna.
  

Moderna Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Moderna can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Moderna Historical Investor Sentiment

Investor biases related to Moderna's public news can be used to forecast risks associated with an investment in Moderna. The trend in average sentiment can be used to explain how an investor holding Moderna can time the market purely based on public headlines and social activities around Moderna. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Moderna's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Moderna and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Moderna news discussions. The higher the estimate score, the more favorable the investor's outlook on Moderna.

Moderna Maximum Pain Price across 2024-05-17 Option Contracts

Moderna's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Moderna close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Moderna's options.
2 days ago at investing.com         
Moderna director Noubar Afeyan sells over 1.8m in company stock
Investing News at Macroaxis
2 days ago at bizjournals.com         
FDA delays decision date for Modernas RSV vaccine
bizjournals News
2 days ago at investing.com         
FDA review of Modernas RSV vaccine delayed to late May
Investing News at Macroaxis
3 days ago at fool.com         
If Youd Invested 1,000 in Moderna Stock 5 Years Ago, Heres How Much Youd Have Today
fool News
3 days ago at investing.com         
Moderna shares target raised to 85 by Deutsche Bank
Investing News at Macroaxis
3 days ago at finance.yahoo.com         
Telesis Bio Reports First Quarter 2024 Financial Results
Yahoo News
3 days ago at finance.yahoo.com         
If Youd Invested 1,000 in Moderna Stock 5 Years Ago, Heres How Much Youd Have Today
Yahoo News
few days ago at www.macroaxis.com         
Disposition of 7996 shares by Noubar Afeyan of Moderna at 122.0689 subject to Rule 16b-3
Macroaxis News
few days ago at finance.yahoo.com         
Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Prot...
Yahoo News
few days ago at gurufocus.com         
Unveiling Moderna s Value Is It Really Priced Right A Comprehensive Guide
Gurufocus Stories at Macroaxis
few days ago at benzinga.com         
Modernas Options Frenzy What You Need to Know
benzinga news
few days ago at gurufocus.com         
Moderna Inc s Uncertain Future Understanding the Barriers to Outperformance
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Acquisition by Noubar Afeyan of 7557 shares of Moderna at 122.13 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Analysts Are Updating Their Moderna, Inc. Estimates After Its First-Quarter Results
Yahoo News
over a week ago at gurufocus.com         
Decoding Moderna Inc A Strategic SWOT Insight
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Moderna that are available to investors today. That information is available publicly through Moderna media outlets and privately through word of mouth or via Moderna internal channels. However, regardless of the origin, that massive amount of Moderna data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Moderna news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Moderna relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Moderna's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Moderna alpha.

Moderna Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Disposition of 705 shares by James Mock of Moderna at 101.9281 subject to Rule 16b-3
04/08/2024
2
Moderna Stock Moves -0.58 percent What You Should Know
04/19/2024
3
Nature Publication Highlights the Benefits of Tropis Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine
04/24/2024
4
Novo Reigns, Stellantis Resilient EMEA Earnings Week Ahead
04/29/2024
5
Moderna Inc s Uncertain Future Understanding the Barriers to Outperformance
05/02/2024
6
Moderna First Quarter 2024 Earnings Beats Expectations
05/03/2024
7
Modernas Options Frenzy What You Need to Know
05/06/2024
8
Disposition of 7996 shares by Noubar Afeyan of Moderna at 122.0689 subject to Rule 16b-3
05/08/2024
9
If Youd Invested 1,000 in Moderna Stock 5 Years Ago, Heres How Much Youd Have Today
05/09/2024
10
FDA delays decision date for Modernas RSV vaccine
05/10/2024
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:
Check out Moderna Hype Analysis, Moderna Correlation and Moderna Performance.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Moderna Stock analysis

When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.85)
Earnings Share
(15.60)
Revenue Per Share
13.525
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.16)
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moderna is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.